Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGEhIV cohort participants

Sebastiaan O. Verboeket; Anders Boyd; Ferdinand W. Wit; Eveline Verheij; Maarten F. Schim van der Loeff; Neeltje Kootstra; Marc van der Valk; Peter Reiss; on behalf of the AGEhIV Cohort Study Group

doi:10.1371/journal.pone.0251205

Loading metrics

Open Access

Peer-reviewed

Research Article

Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGE_hIV cohort participants

Sebastiaan O. Verboeket ,

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Project administration, Validation, Visualization, Writing – original draft, Writing – review & editing

* E-mail: s.o.verboeket@amsterdamumc.nl

Affiliations Department of Internal Medicine, Amsterdam Infection and Immunity Institute and Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands, Department of Global Health, Amsterdam UMC, University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands

https://orcid.org/0000-0002-5626-8327

⨯
Anders Boyd,

Roles Conceptualization, Formal analysis, Methodology, Supervision, Visualization, Writing – original draft, Writing – review & editing

Affiliations HIV Monitoring Foundation, Amsterdam, The Netherlands, Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands
⨯
Ferdinand W. Wit,

Roles Conceptualization, Data curation, Methodology, Writing – original draft, Writing – review & editing

Affiliations Department of Internal Medicine, Amsterdam Infection and Immunity Institute and Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands, Department of Global Health, Amsterdam UMC, University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands, HIV Monitoring Foundation, Amsterdam, The Netherlands
⨯
Eveline Verheij,

Roles Writing – review & editing

Affiliations Department of Internal Medicine, Amsterdam Infection and Immunity Institute and Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands, Department of Global Health, Amsterdam UMC, University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands
⨯
Maarten F. Schim van der Loeff,

Roles Writing – review & editing

Affiliations Department of Internal Medicine, Amsterdam Infection and Immunity Institute and Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands, Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, The Netherlands
⨯
Neeltje Kootstra,

Roles Writing – review & editing

Affiliation Department of Experimental Immunology, Amsterdam Infection and Immunity Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
⨯
Marc van der Valk,

Roles Writing – review & editing

Affiliation Department of Internal Medicine, Amsterdam Infection and Immunity Institute and Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands
⨯
Peter Reiss,

Roles Conceptualization, Funding acquisition, Supervision, Writing – original draft, Writing – review & editing

Affiliations Department of Internal Medicine, Amsterdam Infection and Immunity Institute and Amsterdam Public Health Research Institute, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands, Department of Global Health, Amsterdam UMC, University of Amsterdam and Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands, HIV Monitoring Foundation, Amsterdam, The Netherlands

https://orcid.org/0000-0001-7896-6428

⨯
on behalf of the AGEhIV Cohort Study Group

¶Complete membership of the author group can be found in the Acknowledgments.
⨯

Generally rare but occasionally severe weight gain after switching to an integrase inhibitor in virally suppressed AGE_hIV cohort participants

Sebastiaan O. Verboeket,
Anders Boyd,
Ferdinand W. Wit,
Eveline Verheij,
Maarten F. Schim van der Loeff,
Neeltje Kootstra,
Marc van der Valk,
Peter Reiss,
on behalf of the AGEhIV Cohort Study Group

Published: May 5, 2021
https://doi.org/10.1371/journal.pone.0251205

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Weight gain
Is the Subject Area "Weight gain" applicable to this article?

Thanks for your feedback.
Body weight
Is the Subject Area "Body weight" applicable to this article?

Thanks for your feedback.
Antiretroviral therapy
Is the Subject Area "Antiretroviral therapy" applicable to this article?

Thanks for your feedback.
Obesity
Is the Subject Area "Obesity" applicable to this article?

Thanks for your feedback.
Body mass index
Is the Subject Area "Body mass index" applicable to this article?

Thanks for your feedback.
HIV
Is the Subject Area "HIV" applicable to this article?

Thanks for your feedback.
African people
Is the Subject Area "African people" applicable to this article?

Thanks for your feedback.
Ethnicities
Is the Subject Area "Ethnicities" applicable to this article?

Thanks for your feedback.